New England Congenital Cardiology Association Bicuspid Aortopathy Registry (NECCA BAR): A regional preventive cardiovascular care collaboration

Jonathan N. Flyer,Brett W. Goudie, Emily P. Greenstein,Olga H. Toro-Salazar, Klejda Nikolli,Lynn A. Sleeper,Christopher J. Clarke,Pip Hidestrand,Ruchika Karnik,Sharon E. O'Brien,Mark V. Zilberman,Ronald V. Lacro

Progress in Pediatric Cardiology（2022）

引用 1|浏览9

暂无评分

摘要

•Bicuspid aortopathy carries risk for aortic aneurysm, surgery, dissection and death.•Losartan or atenolol reduced aortic growth rates in a small group of young patients.•Standard clinical recommendations can improve regional management and collaboration.•Larger registry data are needed to track bicuspid aortopathy patients and outcomes.

查看译文

关键词

Bicuspid aortic valve,Bicuspid aortopathy,Atenolol,Losartan,Irbesartan

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要